SCHEMBL7244702

SCHEMBL7244702

O=C(C#CCCCCN1CCOCC1)Oc1ccc2ncnc(Nc3ccc(OCc4cccs4)cc3)c2c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 14/20 0.48
ERBB2 P04626 6/20 0.47
ERBB4 Q15303 3/20 0.47
SRC P12931 3/20 0.45
AURKA O14965 3/20 0.45
AURKB Q96GD4 3/20 0.45
ROCK2 O75116 1/20 0.43
ALDH1A1 P00352 1/20 0.43
LCK P06239 1/20 0.43
FYN P06241 1/20 0.43
RET P07949 1/20 0.43
MET P08581 1/20 0.43
MAPT P10636 1/20 0.43
PDGFRA P16234 1/20 0.43
LTK P29376 1/20 0.43
TTK P33981 1/20 0.43
KDR P35968 1/20 0.43
MAP2K2 P36507 1/20 0.43
MAP2K1 Q02750 1/20 0.43
BTK Q06187 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7242049 0.89 EGFR (0.61) EGFRERBB2ERBB4SRCAURKA
SCHEMBL7233687 0.87 AURKA (0.51) EGFRERBB2ERBB4SRCAURKA
SCHEMBL7242169 0.83 ERBB2 (0.51) EGFRERBB2ERBB4KDR
SCHEMBL7121729 0.81 EGFR (0.49) EGFRERBB2ERBB4SRC
SCHEMBL7125412 0.80 EGFR (0.48) EGFRERBB2ERBB4SRC
SCHEMBL7233992 0.80 ERBB2 (0.47) EGFRERBB2ERBB4SRCAURKA
SCHEMBL7241925 0.80 EGFR (0.56) EGFRERBB2ERBB4AURKAAURKB
SCHEMBL7244172 0.80 EGFR (0.61) EGFRERBB2ERBB4SRCAURKA
SCHEMBL7234893 0.77 EGFR (0.57) EGFRERBB2ERBB4SRCAURKA
SCHEMBL7237483 0.77 EGFR (0.63) EGFRERBB2ERBB4SRCAURKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6127374-A AN ENZYME INHIBITOR FOR TREATING CANCER, RESTENOSIS, ATHEROSCLEROSIS, ENDOMETRIOSIS AND PSORIASIS WARNER-LAMBERT COMPANY (US) 2000-10-03 US claimed
US-6562818-B1 For treating cancer, atherosclerosis, restenosis, endometriosis, and psoriasis WARNER-LAMBERT COMPANY 2003-05-13 US disclosed
US-6127374-A AN ENZYME INHIBITOR FOR TREATING CANCER, RESTENOSIS, ATHEROSCLEROSIS, ENDOMETRIOSIS AND PSORIASIS WARNER-LAMBERT COMPANY (US) 2000-10-03 US disclosed